Vulnerability Description
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.
CVSS Score
LOW
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Philips | Clinical Collaboration Platform | <= 12.2.1 |
Related Weaknesses (CWE)
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party AdvisoryUS Government Resource
- https://www.philips.com/a-w/security/security-advisories/product-security-2020.h
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party AdvisoryUS Government Resource
FAQ
What is CVE-2020-14525?
CVE-2020-14525 is a vulnerability with a CVSS score of 3.5 (LOW). Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is serv...
How severe is CVE-2020-14525?
CVE-2020-14525 has been rated LOW with a CVSS base score of 3.5/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2020-14525?
Check the references section above for vendor advisories and patch information. Affected products include: Philips Clinical Collaboration Platform.